IRF3 regulates neuroinflammatory responses and the expression of genes associated with Alzheimer's disease.

Joshi, Radhika; Brezani, Veronika; Mey, Gabrielle M; Guixé-Muntet, Sergi; Ortega-Ribera, Marti; Zhuang, Yuan; Zivny, Adam; Werneburg, Sebastian; Jordi-Sancho, Gracia; Szabo, Gyongyi (12 March 2024). IRF3 regulates neuroinflammatory responses and the expression of genes associated with Alzheimer's disease. 10.1101/2024.03.08.582968

[img]
Preview
Text
2024.03.08.582968v1.full.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (2MB) | Preview

The pathological role of interferon signaling is emerging in neuroinflammatory disorders, yet, the specific role of Interferon Regulatory Factor 3 (IRF3) in neuroinflammation remains poorly understood. Here, we show that global IRF3 deficiency delays TLR4-mediated signaling in microglia and attenuates the hallmark features of LPS-induced inflammation such as cytokine release, microglial reactivity, astrocyte activation, myeloid cell infiltration, and inflammasome activation. Moreover, expression of a constitutively active IRF3 (S388D/S390D:IRF3-2D) in microglia induces a transcriptional program reminiscent of the Activated Response Microglia and the expression of genes associated with Alzheimer's Disease, notably apolipoprotein-e. Lastly, using bulk-RNAseq of IRF3-2D brain myeloid cells, we identified Z-DNA binding protein-1 as a target of IRF3 that is relevant across various neuroinflammatory disorders. Together, our results identify IRF3 as an important regulator of LPS-mediated neuroinflammatory responses and highlight IRF3 as a central regulator of disease-specific gene activation in different neuroinflammatory diseases.

Item Type:

Working Paper

Division/Institute:

04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Hepatology
04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine

UniBE Contributor:

Jordi, Gracia

Subjects:

600 Technology > 610 Medicine & health

Language:

English

Submitter:

Pubmed Import

Date Deposited:

02 May 2024 10:36

Last Modified:

02 May 2024 10:46

Publisher DOI:

10.1101/2024.03.08.582968

PubMed ID:

38654824

Uncontrolled Keywords:

ARM Activated response microglia Alzheimer’s disease DAM IRF3 IRM Interferon response microglia Neuroinflammation Type 1 interferon ZBP1

BORIS DOI:

10.48350/196373

URI:

https://boris.unibe.ch/id/eprint/196373

Actions (login required)

Edit item Edit item
Provide Feedback